Study summary

The purpose of this study, a follow up to study FG506-CL-0403, is to see how safe and effective Modigraf® is (Part A) and to see how safe and effective it is to change your child's medication from Modigraf® to Prograf® (Part B).

Additional Study Details

Phase
4
Product
N/A
Product
Tacrolimus granules
Tacrolimus capsules
Type
Interventional
Masking
None (Open Label)
Enrollment number
47
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Scientific Results Summary 2
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A paediatric, open, follow up study with Modigraf examining safety and efficacy in de novo allograft recipients? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site FR60 Groupement Hospitalier EST
    Bron, France, 69677
    Completed
    Site ES23 Hospital Universitario La Paz
    Madrid, Spain, 28046
    Completed
    Site ES20 Hospital Universitario La Paz
    Madrid, Spain, 28046
    Completed
    Site FR61 Hopital Robert Debre
    Paris Cedex 19, France, 75945
    Withdrawn
    Site GB11 Great Ormond Street Hospital
    London, United Kingdom, WC1N3JH
    Completed
    Site GB14 Alder Hey Children Hospital
    Liverpool, United Kingdom, L12 2AP
    Completed
    Site ES22 H.U. Gregorio Maranon
    Madrid, Spain, 28007
    Withdrawn
    Site BE41 U.Z. Leuven
    Leuven, Belgium, 3000
    Completed
    Site DE30 Universitätsklin Heidelberg
    Heidelberg, Germany, 69120
    Completed
    Site ES21 Hospital Universitario La Paz
    Madrid, Spain, 28046
    Completed
    Site BE40 Clinique Univ. Saint Luc
    Brussels, Belgium, 1200
    Completed
    Site GB13 Cent. Manchester Uni. Hospital
    Manchester, United Kingdom, M13 9WL
    Completed
    Site DE31 Kliniken der Medizinischen Hoc
    Hannover, Germany, 30625
    Withdrawn
    Site GB10 Birmingham Children's Hospital
    Birmingham, United Kingdom, B4 6NH
    Completed
    Site PL50 Centrum Zdrowia Dziecka
    Warsaw, Poland, 04-730

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?